African cardiomyopathy

Cardiomyopathy africaine

African cardiomyopathy is a genetic heart disease caused by a mutation in the _TAFAZITB_ gene. People with this mutation in the _TAFAZITB_ gene are at high risk of developing cardiomyopathy africa. People with African cardiomyopathy have heart failure and an increased risk of sudden cardiac death.

The main symptom of African cardiomyopathy is _sudden cardiac death_. In most cases, the disease develops rapidly and leads to the rapid development of chronic heart failure. Other symptoms that may occur include dizziness, rapid heartbeat, shortness of breath, fatigue, chest pain, swelling of the legs and sensitivity to exercise.

The sooner treatment begins, the higher the chance of improving the patient's condition. Treatment involves diet, medication, physical therapy and lifestyle changes. Specific medical interventions have not yet been developed to slow or stop the progression of the disease.

Prognosis for cardiomyopathy in